Gender Equality

February 29, 2024 Alnylam Named to Human Rights Campaign’s Corporate Equality Index Alnylam has achieved a score of 90 out of 100 on the Human Rights Campaign's (HRC) 2023-2024 Corporate Equality Index (CEI) based on our US policies, practices, Read More ›
March 29, 2023 Leading by Example in Gender Diversity Among Executive Leadership Alnylam ranked #1 among MA public companies in board of directors gender diversity and #3 in executive leadership gender diversity in the 2023 WPG report.   Read More ›
January 31, 2023 Alnylam Named to Bloomberg's Gender-Equality Index for 3rd Year in a Row Alnylam has been named to Bloomberg's Gender Equality Index (GEI) for the 3rd year in a row. Read More ›
January 26, 2022 Alnylam Named to Bloomberg's Gender-Equality Index for 2nd Year in a Row Alnylam has been named to Bloomberg's 2022 Gender-Equality Index (GEI) - an important diversity, equity and inclusion benchmark, for the 2nd year in a row. Read More ›
September 28, 2021 Alnylam Named a Best Workplace for Working Mothers and Fathers Alnylam has been named a 100 Best Companies (formerly Working Mother's Top 100 Companies) and Best Companies for Dads lists for 2021. Find out why. Read More ›
February 6, 2021 Alnylam Named to Bloomberg's 2021 Gender-Equality Index Alnylam has been selected to Bloomberg's Gender-Equality Index for 2021 Read More ›
March 6, 2020 IWD 2020: Alnylam Women Reflect on Personal Experiences & Inspiration We asked Alnylam women from across the globe to share to share a personal experience or inspiration that has shaped how they view gender and science at work. Read More ›
February 19, 2020 Making Strides in Gender Parity Alnylam ranked #3 in gender parity and #1 in fair representation for Women of Color (WOC) in Executive and Board Leadership among the top 25 employers in MA. Read More ›

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site